Jeffrey Sicat
Endocrinology, Diabetes & Metabolism · Glen Allen, VANPI 1407883689
Payments from drug & device makers
$656,625in general payments, 2019–2025
Across 919 payments — averaging $714.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$461K
- Lilly USA, LLC$183K
- Boehringer Ingelheim$13K
- Currax Pharmaceuticals LLC$137
- Abbott$105
- Vivus LLC$86
- plus $149 from 6 others
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 478 | $460,837 |
| Lilly USA, LLC | 385 | $182,668 |
| Boehringer Ingelheim | 27 | $12,644 |
| Currax Pharmaceuticals LLC | 10 | $137 |
| Abbott | 5 | $105 |
| Vivus LLC | 2 | $86 |
| Eisai Inc. | 3 | $46 |
| Dexcom, Inc. | 2 | $37 |
| Nalpropion Pharmaceuticals LLC | 1 | $20 |
| Amgen | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
| Kvk-tech, Inc. | 4 | $13 |
How this compares
$656,625 in reported general payments places this provider in the 95th percentile of 223 endocrinology, diabetes & metabolism providers in Virginia.
See all endocrinology, diabetes & metabolism providers in Virginia →
Other endocrinology, diabetes & metabolism in Glen Allen
- Domenica RubinoArlington$3M
- Suzanne Jan de BeurCharlottesville$1.5M
- Farhad ZangenehSterling$1.2M
- Ali IranmaneshSalem$1.1M
- Elias SirajNorfolk$884K
- James MulindaRoanoke$788K
- Dewey BaileyRoanoke$645K
- James la RocqueChesapeake$576K
- Samamtha HudsonMidlothian$372K
- Stacey AndersonCharlottesville$314K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.